Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.
Nayak L; Abrey LE; Drappatz J; Gilbert MR; Reardon DA; Wen PY; Prados M; Deangelis LM; Omuro A; Leukemia & Lymphoma, 2013, vol. 54, issue 1, p 58, ISSN 10292403. ISBN 10292403.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef